ACCESSION: MSBNK-SMB_Measured-HSA033P0112001
RECORD_TITLE: Annotated; Creatinine; LC-ESI-QTOF; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.03.25 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.03.25, Curated 2025.03.25)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 60
COMMENT: RAW_SPEC {'C1neg_2322': {'bp': 6911.0, 'sum': 9662.0}, 'D64neg_2430': {'bp': 6534.0, 'sum': 9684.0}, 'C1neg_2309': {'bp': 6351.0, 'sum': 9321.0}, 'C6neg_2417': {'bp': 6097.0, 'sum': 8569.0}, 'C13neg_2394': {'bp': 6000.0, 'sum': 8057.0}, 'C17neg_2331': {'bp': 5988.0, 'sum': 8223.0}, 'C6neg_2378': {'bp': 5949.0, 'sum': 8913.0}, 'C15neg_2319': {'bp': 5908.0, 'sum': 7963.0}, 'C16neg_2343': {'bp': 5769.0, 'sum': 8250.0}, 'D73neg_2431': {'bp': 5475.0, 'sum': 8453.0}, 'C17neg_2344': {'bp': 5432.0, 'sum': 7737.0}, 'C7neg_2383': {'bp': 5077.0, 'sum': 7064.0}, 'D65neg_2421': {'bp': 5012.0, 'sum': 7253.0}, 'C12neg_2321': {'bp': 4933.0, 'sum': 7006.0}, 'C16neg_2330': {'bp': 4822.0, 'sum': 7706.0}, 'D74neg_2332': {'bp': 4593.0, 'sum': 6685.0}, 'C4neg_2321': {'bp': 4587.0, 'sum': 7341.0}, 'D108neg_2307': {'bp': 4549.0, 'sum': 6506.0}, 'D65neg_2408': {'bp': 4435.0, 'sum': 6238.0}, 'C14neg_2267': {'bp': 4405.0, 'sum': 6186.0}, 'D146neg_2372': {'bp': 4367.0, 'sum': 6006.0}, 'C4neg_2360': {'bp': 4340.0, 'sum': 6252.0}, 'D108neg_2424': {'bp': 4282.0, 'sum': 7081.0}, 'D146neg_2333': {'bp': 4184.0, 'sum': 6745.0}, 'D170neg_2329': {'bp': 4099.0, 'sum': 5428.0}, 'C7neg_2435': {'bp': 4027.0, 'sum': 6002.0}, 'D143neg_2351': {'bp': 3986.0, 'sum': 5899.0}, 'C14neg_2293': {'bp': 3964.0, 'sum': 5280.0}, 'D84neg_2380': {'bp': 3958.0, 'sum': 5888.0}, 'D170neg_2342': {'bp': 3851.0, 'sum': 5562.0}, 'C13neg_2329': {'bp': 3776.0, 'sum': 5444.0}, 'C12neg_2308': {'bp': 3735.0, 'sum': 6162.0}, 'D74neg_2345': {'bp': 3702.0, 'sum': 5559.0}, 'D65neg_2343': {'bp': 3310.0, 'sum': 5795.0}, 'C6neg_2313': {'bp': 3181.0, 'sum': 4635.0}, 'C16neg_2408': {'bp': 3152.0, 'sum': 6000.0}, 'D136neg_2336': {'bp': 3064.0, 'sum': 5147.0}, 'D143neg_2390': {'bp': 3056.0, 'sum': 4969.0}, 'C1neg_2387': {'bp': 3031.0, 'sum': 4303.0}, 'D143neg_2286': {'bp': 2958.0, 'sum': 4648.0}, 'C16neg_2265': {'bp': 2948.0, 'sum': 4185.0}, 'D136neg_2271': {'bp': 2889.0, 'sum': 4005.0}, 'C12neg_2243': {'bp': 2860.0, 'sum': 4243.0}, 'D74neg_2267': {'bp': 2807.0, 'sum': 4199.0}, 'D102neg_2358': {'bp': 2772.0, 'sum': 4221.0}, 'D108neg_2294': {'bp': 2767.0, 'sum': 3943.0}, 'D136neg_2349': {'bp': 2697.0, 'sum': 4514.0}, 'C1neg_2244': {'bp': 2622.0, 'sum': 3868.0}, 'C4neg_2399': {'bp': 2357.0, 'sum': 3778.0}, 'C17neg_2266': {'bp': 2267.0, 'sum': 3795.0}, 'C14neg_2202': {'bp': 1928.0, 'sum': 2907.0}, 'D102neg_2267': {'bp': 1926.0, 'sum': 2965.0}, 'C7neg_2461': {'bp': 1361.0, 'sum': 1907.0}, 'D102neg_2410': {'bp': 1309.0, 'sum': 2023.0}, 'C15neg_2241': {'bp': 1264.0, 'sum': 1936.0}, 'C4neg_2243': {'bp': 1063.0, 'sum': 1567.0}, 'C14neg_2189': {'bp': 984.0, 'sum': 1446.0}, 'D146neg_2255': {'bp': 831.0, 'sum': 1629.0}, 'C12neg_2230': {'bp': 717.0, 'sum': 1389.0}, 'C16neg_2252': {'bp': 616.0, 'sum': 1120.0}}
COMMENT: RETENTION_TIME_STDEV 0.043
COMMENT: PRECURSOR_M/Z_RAW 112.052299
COMMENT: PRECURSOR_M/Z_STDEV 0.000389
COMMENT: PRECURSOR_IN_MS1 mz 112.052462; int 147.588; delta(ppm) 1.069524
COMMENT: PROPOSED_CHARGE_STATE -1; mz 113.055077; int 6.430; cor 0.931
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M+Cl; mz 148.028613; int 16.445; cor 0.896
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 7.032; C4H7N3O; [M-H]1; delta(ppm) 7.031683
COMMENT: PROPOSED_MF MS-FINDER 3.649; C4H7N3O; [M-H]-; delta(ppm) 7.099980
COMMENT: PROPOSED_MF SIRIUS5_Sirius 16.157; C4H7N3O; [M-H]-; delta(ppm) 7.099980
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H7N3O; [M-H]-; delta(ppm) 7.099980
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.936; C4H7N3O; [M-H]-; delta(ppm) 7.099980
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.776; C6H9O2; [M-H]-; delta(ppm) -4.882505
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H7N3O; [M-H]-; delta(ppm) 7.099980
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 5.000; DDRJAANPRJIHGJ-UHFFFAOYSA-N; C4H7N3O; Massbank:KO000424 Creatinine1-Methylglycocyamidine
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.810; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M-H]-; CN1C=C(O)N=C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.714; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M-H]-; CN1CC(=O)NC1=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.508; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M-H]-; CN(CCC#N)N=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.500; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M-H]-; C1C=CNN1C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; KFSQJVOLYQRELE-UHFFFAOYSA-M; [M-H]-; CCC(=CC)C([O-])=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.149; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M-H]-; Creatinine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.374; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M-H]-; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.281; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M-H]-; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.281; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M-H]-; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M-H]-; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.966; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M-H]-; Creatinine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.931; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M-H]-; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.519; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M-H]-; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.741; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M-H]-; 2-amino-3-methyl-4H-imidazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; GZDJNVITGJORKZ-UHFFFAOYSA-N; [M-H]-; ethyl N'-cyanocarbamimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.995; XHSTYRIUVMKGDX-UHFFFAOYSA-N; [M-H]-; 5-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.973; OMFADAFZDYXVOK-UHFFFAOYSA-N; [M-H]-; 5-ethyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M-H]-; N-(2-cyanoethyl)-N-methylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.963; FOOFYKFJNMAAQE-UHFFFAOYSA-N; [M-H]-; N-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.958; XGKOIOPVLYCTRF-UHFFFAOYSA-N; [M-H]-; 5-amino-2-methyl-4H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; HKIXGXYGOILGSX-UHFFFAOYSA-N; [M-H]-; 2-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; YUTNQQHHUYYBFA-UHFFFAOYSA-N; [M-H]-; N-methyl-1-(1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; CIHQZPVUYBHNQO-UHFFFAOYSA-N; [M-H]-; 1-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; HGPUJQWMCPURNO-UHFFFAOYSA-N; [M-H]-; 3-ethyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.866; LODVFGWSULLZAU-UHFFFAOYSA-N; [M-H]-; 4-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.812; OTERRMWTPZGJLB-UHFFFAOYSA-N; [M-H]-; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.777; HNXYWYOVPHLAQF-UHFFFAOYSA-N; [M-H]-; N,4-dimethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.768; DLLDJWMWMVUIDZ-UHFFFAOYSA-N; [M-H]-; (3-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.754; YGVFIVSNVVUSCS-UHFFFAOYSA-N; [M-H]-; 5-amino-2-methyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.750; KXLLKSHFFVQKTQ-UHFFFAOYSA-N; [M-H]-; 2-cyanoethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.746; RTCYUGLJCAPLPD-UHFFFAOYSA-N; [M-H]-; (2-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.738; DSFUCCQCXNNWLA-UHFFFAOYSA-N; [M-H]-; 3-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.729; IRPLFUJJHBGEAL-UHFFFAOYSA-N; [M-H]-; 3-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.726; AUZHYHBJZVEQNI-UHFFFAOYSA-N; [M-H]-; 4-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.705; QUAQZVSGXQVIEP-UHFFFAOYSA-N; [M-H]-; (2-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.703; VUYWQWFWWHLKFG-UHFFFAOYSA-N; [M-H]-; 4-amino-5-methyl-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.702; YWXPPKJKSSLZOD-UHFFFAOYSA-N; [M-H]-; 5-(methoxymethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.702; WYZRLXYOIMXEBO-UHFFFAOYSA-N; [M-H]-; 1-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.701; MKSFCAQPDWJPND-UHFFFAOYSA-N; [M-H]-; 5-(aminomethyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.689; NZORXPUYHVZTQG-UHFFFAOYSA-N; [M-H]-; (3-amino-1H-pyrazol-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.670; CIFUFRVSHZKBEO-UHFFFAOYSA-N; [M-H]-; (4-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.649; WEDYTSQNYJKOPC-UHFFFAOYSA-N; [M-H]-; (1-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.620; HJEVQOSZWIDFQJ-UHFFFAOYSA-N; [M-H]-; 2-(2H-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; PKHVUMMJMYKRNO-UHFFFAOYSA-N; [M-H]-; 2-(triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.594; LFSXUCZAZSQBPW-UHFFFAOYSA-N; [M-H]-; 1-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.594; HUSLEZCKWCUICB-UHFFFAOYSA-N; [M-H]-; 2-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.594; XJUQLFVCCWNFJJ-UHFFFAOYSA-N; [M-H]-; N-methyl-1-(1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.588; XKKMMJLWDOKNEW-UHFFFAOYSA-N; [M-H]-; (1-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.565; PFBCKBGKRFYNLE-UHFFFAOYSA-N; [M-H]-; (5-methyl-2H-triazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.548; CLVALLQETQTQMV-UHFFFAOYSA-N; [M-H]-; 2-(1,2,4-triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.540; KNIARYZRPMJYFH-UHFFFAOYSA-N; [M-H]-; 2-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.511; YOSYLAYVXLOORB-UHFFFAOYSA-N; [M-H]-; 2-(1,2,4-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.498; NPBUMVMXXGQOEG-UHFFFAOYSA-N; [M-H]-; (3-methyl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.498; KPBSGOLXLCARIL-UHFFFAOYSA-N; [M-H]-; (5-methyl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.492; BMTFHVKZYIOHBE-UHFFFAOYSA-N; [M-H]-; (5-methyl-1H-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.440; BVNFZLFQKJYVDJ-UHFFFAOYSA-N; [M-H]-; 3,4-dimethyl-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.438; YKTPXKSUWIQBML-UHFFFAOYSA-N; [M-H]-; (4-methyl-1,2,5-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.241; MTHUPGKUEISSDE-UHFFFAOYSA-N; [M-H]-; 2-amino-N-(cyanomethyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -14.087; DDRJAANPRJIHGJ; [M-H]-; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.856; CMIPWACBRYWGPN; [M-H]-; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.593; KXLLKSHFFVQKTQ; [M-H]-; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -217.934; HZDLDFBKYBGNHG; [M-H]-; 3-Methylnitrosaminopropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.135; CLVALLQETQTQMV; [M-H]-; triazolylethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -290.603; OMFADAFZDYXVOK; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -293.554; IRPLFUJJHBGEAL; [M-H]-; 5-amino-1-methyl-1H-pyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -293.566; DLLDJWMWMVUIDZ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -304.291; OTERRMWTPZGJLB; [M-H]-; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -306.257; HGPUJQWMCPURNO; [M-H]-; Ambcb4035725
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -312.787; RTCYUGLJCAPLPD; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -323.187; PKHVUMMJMYKRNO; [M-H]-; 2-(1-triazolyl)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -339.197; XHSTYRIUVMKGDX; [M-H]-; 2-NH2-5-ET-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -340.837; MKSFCAQPDWJPND; [M-H]-; Azamuscimol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.908; DDRJAANPRJIHGJ; [M-H]-; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -13.318; DDRJAANPRJIHGJ; [M-H]-; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -86.692; XGKOIOPVLYCTRF; [M-H]-; 3-amino-1-methyl-4,5-dihydro-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -108.111; PPVUWDCETZMPLT; [M-H]-; 5-Dihydro-1h-pyrazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -118.644; BVNFZLFQKJYVDJ; [M-H]-; 3H-1,2,4-Triazol-3-one, 2,4-dihydro-4,5-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -123.236; KXLLKSHFFVQKTQ; [M-H]-; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -131.102; CMIPWACBRYWGPN; [M-H]-; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -149.886; HZDLDFBKYBGNHG; [M-H]-; 3-(Methyl-D3-nitrosoamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -158.706; IRPLFUJJHBGEAL; [M-H]-; 5-amino-1-methyl-1H-pyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -167.758; XHSTYRIUVMKGDX; [M-H]-; 5-Ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -175.581; OMFADAFZDYXVOK; [M-H]-; 5-Ethyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.677; DDRJAANPRJIHGJ; [M-H]-; Kreatinin
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Creatinine, DDRJAANPRJIHGJ-UHFFFAOYSA-N; Matching to 5 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (2), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000562;
CH$NAME: Creatinine
CH$NAME: 2-amino-3-methyl-4H-imidazol-5-one
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C4H7N3O
CH$EXACT_MASS: 113.058912
CH$SMILES: CN1CC(=O)N=C1N
CH$IUPAC: InChI=1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)
CH$LINK: CHEBI CHEBI:16737
CH$LINK: HMDB HMDB0000562
CH$LINK: INCHIKEY DDRJAANPRJIHGJ-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:588
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 µm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 2.716
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 112.052431
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-9000000000-dbee70598811d2b8552f
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  40.0075995 83.4884 40.007590 10.0231 35.77 0.6122 49 f{C1N2}/22.57ppm,p-C3H6N1O1
  41.0155669 999.0000 41.015560 4.6811 0.00 0.8183 60 f{C1H1N2}/25.48ppm,p-C3H5N1O1
  41.9995042 84.0424 41.999500 8.5953 30.45 0.6962 53 f{C1N1O1}/23.02ppm,p-C3H6N2
  68.0023019 83.6482 68.002265 8.0291 31.98 0.6471 58 f{C2N2O1}/10.16ppm,p-C2H6N1
  79.9584603 55.1278 79.958410 10.0677 44.77 0.1606 45 ?
  112.0522834 142.7671 112.052240 6.9253 37.08 1.0000 54 f{C4H6N3O1}/5.78ppm,p
PK$NUM_PEAK: 6
PK$PEAK: m/z int. rel.int.
  40.007599 83.49 83
  41.015567 999.00 999
  41.999504 84.04 84
  68.002302 83.65 83
  79.958460 55.13 55
  112.052283 142.77 142
//
